{
  "docId": "019de074-ddab-749d-b286-5e01e8bcb935",
  "docSlug": "f43e68719e672319f390e5844d5bc5fe",
  "documentTitle": "Chimerix | Investor Presentation Deck | 41 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 36,
  "pageCount": 41,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide includes a visual comparison of tumor burden in mice models (Vehicle vs ONC201 vs ONC212).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-ddab-749d-b286-5e01e8bcb935/36",
  "deckHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935",
  "deckJsonHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935.json",
  "deckAnchorHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.29,
        "w": 0.23,
        "x": 0.62,
        "y": 0.43
      },
      "kind": "image",
      "text": "Vehicle, ONC201, ONC212 mouse imaging comparison",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3ce8122-32a7-4265-b92a-03011accc02f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.54,
        "x": 0.04,
        "y": 0.24
      },
      "kind": "list",
      "text": "Distinct molecular target (GPR132) and efficacy profile relative to ONC201/ONC206\nEfficacy in preclinical models of advanced cancers\nGLP-tox studies complete, potential to advance to IND\nPartnerships established for early-stage clinical trials with Brown University and MD Anderson Cancer Center",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d939328-dcf3-4785-ae87-0ecf7d1c6bc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.28,
        "x": 0.59,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Pancreatic cancer model shows the potential of ONC212",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b58558ed-faf1-41ac-8c68-469792a59c9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.11,
        "x": 0.1,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. Lev et al, Oncotarget 2017",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59705741-c870-4d01-88ef-83002b796920",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.46,
        "x": 0.27,
        "y": 0.06
      },
      "kind": "title",
      "text": "ONC212: GPR132 + ClpP Agonist",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c10efe7-0a28-4857-9be9-42d919123989",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "43693c88-5cca-4aa4-a3c7-debc57845301",
      "evidence": "list/bullet: Distinct molecular target (GPR132) and efficacy profile relative to ONC201/ONC206",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}